Navigate
X
    QualityStocks
  • 17 years ago

Synvista Therapeutics, Inc. (AMEX: SYI)

Synvista Therapeutics, Inc. (AMEX: SYI), a biopharmaceutical company, is focused on the development of drugs to treat and prevent cardiovascular disease and nephropathy in people with diabetes. The Company has identified multiple product candidates innovatively approach some of the largest pharmaceutical markets. The Company’s portfolio includes orally bioavailable, organoselenium mimics of glutathione peroxidase. For further information, visit the Company’s web site at www.alteon.com.

Tags Rodman & Renshaw
Related Post
  1. QualityStocksNewsBreaks – Powering AI: Nicola Mining Inc.’s (TSX.V: NIM) (OTCQB: HUSIF) Copper Project Aligns with Data Center Surge

    As artificial intelligence (“AI”) continues to revolutionize industries, the infrastructure supporting its growth has become…

  2. Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Breaks Ground on REE Processing Facility, Pioneers Domestic Supply Chain

    The company announced the groundbreaking of its Louisiana Strategic Metals Complex (“SMC”) in Alexandria. The…

  3. NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100

    The new FDA voucher program aims to speed approval of drugs aligned with national health…